Similar articles for PMID: 21724930

Year	Number of Results
1978	1
1998	1
1999	1
2000	1
2001	1
2002	1
2003	3
2004	5
2005	5
2006	4
2007	5
2008	5
2009	4
2010	8
2011	20
2012	19
2013	12
2014	9
2015	5
2016	2
2017	1
2018	2
2019	3
2020	4
2021	2
2022	4
2024	0

1

Tang DM, Ward L. Tang DM, et al. Cleve Clin J Med. 2011 Jul;78(7):472-4. doi: 10.3949/ccjm.78a.10124. Cleve Clin J Med. 2011. PMID: 21724930 Free article. No abstract available.

2

When good drugs turn weirdly bad.

Mandell BF. Mandell BF. Cleve Clin J Med. 2011 Jul;78(7):426. doi: 10.3949/ccjm.78b.11007. Cleve Clin J Med. 2011. PMID: 21724925 Free article. No abstract available.

3

Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.

Quinn D, Kuchler E, Deming P, Arora S. Quinn D, et al. Psychosomatics. 2012 Jul-Aug;53(4):400-1. doi: 10.1016/j.psym.2012.02.007. Psychosomatics. 2012. PMID: 22748752 No abstract available.

4

Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.

Rongioletti F, Fausti V, Parodi A. Rongioletti F, et al. Arch Dermatol. 2012 Oct;148(10):1213-4. doi: 10.1001/archdermatol.2012.1968. Arch Dermatol. 2012. PMID: 23069974 No abstract available.

5

Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.

Hu CC, Chien RN. Hu CC, et al. Aliment Pharmacol Ther. 2013 Feb;37(4):492. doi: 10.1111/apt.12189. Aliment Pharmacol Ther. 2013. PMID: 23336679 Free article. No abstract available.

6

Severe renal impairment during triple therapy with telaprevir.

Carrier P, Chambaraud T, Vong C, Guillaudeau A, Debette-Gratien M, Jacques J, Legros R, Sautereau D, Essig M, Loustaud-Ratti V. Carrier P, et al. Clin Res Hepatol Gastroenterol. 2014 Sep;38(4):e69-71. doi: 10.1016/j.clinre.2013.12.005. Epub 2014 Jan 22. Clin Res Hepatol Gastroenterol. 2014. PMID: 24461554 No abstract available.

7

[Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].

Virolés Torrent S, López Nuñez C, Hombrados Verde M, Figa Francesch M, Ferri Iglesias MJ, Louvriex Freire R, Acero Fernández D. Virolés Torrent S, et al. Gastroenterol Hepatol. 2015 Feb;38(2):78-81. doi: 10.1016/j.gastrohep.2014.04.003. Epub 2014 Jun 16. Gastroenterol Hepatol. 2015. PMID: 24948444 Spanish. No abstract available.

8

[Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].

Castellanos González M, Pérez Carreras M, Muñoz Gómez R, Castellano Tortajada G. Castellanos González M, et al. Gastroenterol Hepatol. 2011 Oct;34(8):584-5. doi: 10.1016/j.gastrohep.2011.03.017. Epub 2011 Jun 8. Gastroenterol Hepatol. 2011. PMID: 21641684 Spanish. No abstract available.

9

[Information for patients. Treatment of acute hepatitis C].

Otón Nieto E. Otón Nieto E. Rev Esp Enferm Dig. 2011 Oct;103(10):549. doi: 10.4321/s1130-01082011001000010. Rev Esp Enferm Dig. 2011. PMID: 22054273 Free article. Spanish. No abstract available.

10

Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.

di Meo N, Stinco G, Fadel M, Errichetti E, Trevisan G. di Meo N, et al. J Cutan Med Surg. 2015 May-Jun;19(3):203-4. doi: 10.1177/1203475415583413. J Cutan Med Surg. 2015. PMID: 26060126 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year